Search
for

    Research 10 of 1000+

    1. Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC). Journal of Clinical Oncology · 2011 · 2 citations
    2. Phase I-II trial of weekly bicalutamide in men with high PSA and negative biopsy Journal of Clinical Oncology · 2007 · 1 citations
    3. Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI) European Journal of Cancer · 2010 · 93 citations
    4. THU0301 A Phase II Trial of Retinoids on Lupus Nephritis in A Single Center Annals of the rheumatic diseases · 2016 · 1 citations
    5. Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial British Journal of Dermatology · 2026
    6. Safety and efficacy of tavaborole (AN2690), a novel boron-based molecule, in 3 phase II trials for the topical treatment of toenail onychomycosis Journal of The American Academy of Dermatology · 2014
    7. A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol BMC Cancer · 2024 · 4 citations
    8. A Prospective Open Labelled Phase-II Non Randomized Clinical Trial On “Karunjchirakam Chooranam” for Raktha Soorai Vaayu (Poly Cystic Ovarian Syndrome) 2019
    9. Discussion of “A hybrid phase I‐II/III clinical trial design allowing dose re‐optimization in phase III” by Andrew G. Chapple and Peter F. Thall Biometrics · 2019
    10. ISID1077 – Efficacy and safety of ENERGI-F701 solution versus 2% minoxidil solution for female pattern hair loss: a phase II, multi-center, randomized, double-blind, head-to-head, parallel trial 2023
    All research results →

    Community 10 of 420

    1. About Pyrilutamide Phase II US Trial Reddit · 13 Sept 2023
    2. GT20029 China Phase II Trial For AGA Reached Primary Endpoint Reddit · 21 Apr 2024
    3. Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China Reddit · 22 Aug 2023
    4. HMI-115 Australian Phase 1 Trial completed? Reddit · 18 Oct 2023
    5. GT20029 phase II results release date? Reddit · 9 Jan 2024
    6. GT20029 Big Phase 2 Update Results! Reddit · 6 Dec 2025
    7. GT20029 - Promising phase II results Reddit · 28 Apr 2024
    8. KX-826 1% Phase II Results from China Just Dropped Reddit · 31 Jul 2025
    9. The story of RU58841/PSK3841 Community · 13 Aug 2024
    10. So why did the first pyrilutamide phase III fail? Reddit · 7 Aug 2026
    All community results →

    Learn 4 of 27

    1. Finasteride Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically
    2. RU58841 Experimental topical anti-androgen sold as a research chemical
    3. Pyrilutamide Experimental topical anti-androgen, also known as KX-826
    4. GT20029 Experimental topical drug designed to break down androgen receptors
    All learn results →